ArticleWorld journal of surgical oncology2026
LY86-AS1 predicts poor prognosis and inhibits progression in non-small cell lung cancer by targeting the miR-132-3p/RB1CC1 axis.
Yang Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.